Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Pegylated Liposomal Doxorubicin, Ovarian Cancer

Andrejs Kuksis

MD

🏢Princess Margaret Cancer Centre🌐Canada

Medical Oncologist

28
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Andrejs Kuksis is a gynecologic oncology specialist with expertise in systemic chemotherapy including pegylated liposomal doxorubicin (PLD) for platinum-resistant ovarian cancer. His clinical work focuses on optimizing chemotherapy regimens and managing toxicities in heavily pre-treated ovarian cancer patients. He has contributed to clinical research on combination strategies pairing PLD with targeted agents such as PARP inhibitors and bevacizumab. His practice at Princess Margaret Cancer Centre reflects a multidisciplinary approach to recurrent ovarian cancer.

Share:

🧪Research Fields 研究领域

pegylated liposomal doxorubicin
PLD ovarian cancer
platinum-resistant ovarian cancer
chemotherapy ovarian
ovarian cancer salvage therapy

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Andrejs Kuksis 的研究动态

Follow Andrejs Kuksis's research updates

留下邮箱,当我们发布与 Andrejs Kuksis(Princess Margaret Cancer Centre)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment